Tepmetko 225mg Tablet is a medication that contains Tepotinib as an active agent. The primary benefit of this medication is its ability to slow down or stop the growth and prevent the spread of cancer cells in the body, particularly in patients with non-small cell lung cancer (NSCLC) that has a mutation in the MET gene (surface of certain cancer cells). Another potential benefit of Tepmetko 225mg Tablet is that it may have fewer side effects when compared to traditional chemotherapy. However, it can still cause side effects like nausea, vomiting, and fatigue. Patients who are allergic to Tepmetko 225mg Tablet or its components should not use this medication.

Patients with previous heart, kidney, lung, and liver disease should talk to a doctor before taking this medication. This medicine has not been studied in elderly patients, so its use in this population requires careful monitoring. Patients receiving it are monitored for signs of bleeding, such as hemoptysis (coughing up blood), melena (dark, tarry stools), or hemorrhagic shock. It is recommended to avoid consuming large amounts of grapefruit or grapefruit juice, as it can increase the risk of adverse reactions or interactions with some medications.

VERY SECURE PAYMENT METHODS
SHIPPING WILL BE CALCULATED ON CHECKOUT
PLEASE NOTE THAT PRICES MAY INCREASE DUE TO EXCHANGE RATE, ENSURE UPDATED PRICE BEFORE MAKING PAYMENT